News

BMJ1d
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
26 Sorbonne Université, INSERM, Institut Pierre Louis d"Epidémiologie et de Santé Publique, Paris and Pitié Salpêtrière hospital, AP-HP, Rheumatology Department, Paris, France 27 Strasbourg University ...
BMJ1d
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Correspondence to Dr Antonis Fanouriakis, Rheumatology and Clinical Immunology Unit, “Attikon” University Hospital, Athens 12462, Greece; afanour{at}med.uoa.gr Our objective was to update the EULAR ...
BMJ6d
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine
Professor D L Scott, King's College Hospital, East Dulwich Grove, Dulwich, London SE22 8PT, UKleigh.joyce{at}kcl.ac.uk OBJECTIVE Recent studies have demonstrated the short term efficacy of leflunomide ...
BMJ6d
Classification and diagnostic criteria for psoriatic arthritis
1 Rheumatology and Rehabilitation Research Unit, University of Leeds, Leeds, UK 2 Rehabilitation Teaching and Research Unit, Department of Medicine, Wellington School of Medicine and Health Sciences, ...